LuciOsim (Osimertinib) 80mg*30 | Lucius Laos Generic | GLT

Generic Information: LuciOsim (Osimertinib) 80mg — Laos

LuciOsim is the osimertinib generic produced by Lucius Pharmaceuticals (Lao) Co., Ltd., a recently established Vientiane-based manufacturer that specialises in oncology generics. The product is supplied as 80 mg film-coated tablets in 30-tablet packs. Lucius has built a portfolio of targeted-therapy generics — including osimertinib, sotorasib and lorlatinib — and has obtained marketing approvals for dozens of anticancer products, distributing across multiple Southeast Asian markets and beyond.

For buyers, LuciOsim is a Lao-sourced generic with an identifiable, cancer-focused manufacturer. The active ingredient and dose mirror the originator Tagrisso, and batch verification against Lucius documentation is straightforward.

What Is LuciOsim Used For?

LuciOsim is used for EGFR mutation-positive non-small cell lung cancer, covering first-line advanced disease, adjuvant therapy after surgery in eligible patients, and T790M-positive disease after resistance to a prior EGFR TKI. Its central nervous system penetration supports use in patients with brain metastases.

How Does LuciOsim Work?

Osimertinib, the active ingredient, irreversibly inhibits mutated EGFR, including the T790M resistance mutation and the common sensitising mutations (exon 19 deletion, L858R), while sparing wild-type EGFR. This mutant-selective mechanism underlies its broad clinical utility and its comparatively mild skin and gastrointestinal toxicity.

Indications

• First-line advanced EGFR-mutant NSCLC.
• Adjuvant therapy after resection of EGFR-mutant NSCLC.
• T790M-positive NSCLC after prior EGFR-TKI therapy.

Dosage and Administration

Take one 80 mg tablet once daily, with or without food, swallowed whole. Do not crush or split the tablet. Missed doses beyond 12 hours are omitted. A 40 mg daily dose may be used for toxicity, and treatment continues until progression or intolerance.

Side Effects

Common side effects include diarrhoea, rash, dry skin, nail toxicity, stomatitis and fatigue. Serious but uncommon risks include interstitial lung disease, QT prolongation and cardiomyopathy; patients should report new cough, breathlessness or palpitations and receive routine monitoring.

Storage

Store LuciOsim below 30°C, in the original bottle, in a dry place, out of children's reach. Use before the printed expiry date.

Why Choose the GLT?

GLT verifies LuciOsim batches against Lucius Pharmaceuticals' documentation and offers a traceable Lao supply route. Lao osimertinib generics are typically several times cheaper than branded Tagrisso in Western markets, which helps patients and institutions sustain long-term targeted therapy. We provide clear purchase documentation and responsive support from inquiry through delivery.

How to Order LuciOsim from GLT

Contact GLT on WhatsApp at +86 15234153837 or email [email protected] to order LuciOsim 80 mg (30 tablets). Provide your quantity, destination and order type, and we will confirm availability, batch documentation and shipping terms.

FAQ

Who manufactures LuciOsim? LuciOsim is manufactured by Lucius Pharmaceuticals (Lao) Co., Ltd. in Vientiane, Laos.

Is LuciOsim a generic of Tagrisso? Yes, LuciOsim contains the same active ingredient (osimertinib) at the same 80 mg dose.

Can I order LuciOsim online? Yes, GLT supplies LuciOsim internationally; contact us via WhatsApp or email.